JAMA Psychiatry

Article	Citations
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	720
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	641
Internet-Based Cognitive Behavioral Therapy for Depression	476
Association Between Physical Activity and Risk of Depression	429
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	414
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	363
How COVID-19 Affects the Brain	301
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	295
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	271
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	262
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	255
From Basic Science to Clinical Application of Polygenic Risk Scores	223
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	189
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	183
Could Polygenic Risk Scores Be Useful in Psychiatry?	180
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	179
Probability of Transition to Psychosis in Individuals at Clinical High Risk	177
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	170
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	167
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	164
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	163
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	156
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	156
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	154
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	146

Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	145
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	140
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	137
Adjunctive Psychotherapy for Bipolar Disorder	134
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	132
Effect of Zuranolone vs Placebo in Postpartum Depression	131
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	130
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	128
The Current Status of Psychedelics in Psychiatry	126
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	124
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	121
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	119
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	118
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	116
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	115
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	113
Association of Drug Cues and Craving With Drug Use and Relapse	112
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	109
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	104
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	100
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	99
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	95
Association Between Ambient Heat and Risk of Emergency Department Visits for Mental Health Among US Adults, 2010 to 2019	94
Association of Cannabis Use During Adolescence With Neurodevelopment	94
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	93
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	89
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	86
Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons	85
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	85
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia	85
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis	85
Contingency Management for Patients Receiving Medication for Opioid Use Disorder	84
Association of US Nurse and Physician Occupation With Risk of Suicide	84
Association of Screen Time With Internalizing and Externalizing Behavior Problems in Children 12 Years or Younger	83
Prediction, Not Association, Paves the Road to Precision Medicine	80
Stratified Care vs Stepped Care for Depression	80
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	80
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic	79
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	79
Emergency Department Encounters Among Youth With Suicidal Thoughts or Behaviors During the COVID-19 Pandemic	77
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia	77
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	77
Suicide Prevention in the COVID-19 Era	74
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries	71
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	71
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019	71
Longitudinal Associations of Mental Disorders With Dementia	69
Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals	68
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment	68
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects	67

Long-term Exposure to Multiple Ambient Air Pollutants and Association With Incident Depression and Anxiety	67
Association of Hypothyroidism and Clinical Depression	66
Preaddiction—A Missing Concept for Treating Substance Use Disorders	65
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia	63
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	62
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence	61
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	61
Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017	58
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	58
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder	57
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	57
Cost-effectiveness of Treatments for Opioid Use Disorder	57
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder	57
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	56
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness	55
Use of Medications for Alcohol Use Disorder in the US	55
Psychedelic Drug Legislative Reform and Legalization in the US	55
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	55
Meeting Maternal Mental Health Needs During the COVID-19 Pandemic	54
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia	54
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	54
Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder	54
Preparing for the Bursting of the Psychedelic Hype Bubble	54
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	54
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails	54
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	54
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	54
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness	53
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	53
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	52
Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits	52
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population	52
Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders	52
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults	52
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	52
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders	52
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	52
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US	51
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder	51
Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia	51
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care	50
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions	50
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia	50
Why Deaths of Despair Are Increasing in the US and Not Other Industrial Nations—Insights From Neuroscience and Anthropology	49
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark	49
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	49
Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	49
Prevalence of Perinatal Depression in Low- and Middle-Income Countries	49
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	49
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	49
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia	48
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	47
Current Epidemiological Trends in Firearm Mortality in the United States	47
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	47
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder	47
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals	46
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	46
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression	46
Race as a Social Construct in Psychiatry Research and Practice	46
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	46
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals	45
Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence and Their Implications for Psychiatric Disorders	45
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients	44
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder	44
Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US	44
Association of History of Psychopathology With Accelerated Aging at Midlife	43
Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals	43
Driving Performance and Cannabis Users’ Perception of Safety	43
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	43
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study	42
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	42
Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder	42
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	42
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States	41
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries	41
Removing the Reliability Bottleneck in Functional Magnetic Resonance Imaging Research to Achieve Clinical Utility	41
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19	40
Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults	40
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia	40
Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms	40

Socioeconomic Indicators of Treatment Prognosis for Adults With Depression	40
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death	40
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression	40
Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores	39
Changes and Inequities in Adult Mental Health–Related Emergency Department Visits During the COVID-19 Pandemic in the US	39
Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya	39
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	39
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands	39
Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count	38
Social Determinants of Mental Health	38
Effect of Online 1-Day Cognitive Behavioral Therapy–Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression	38
Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation	38
Association of Borderline Personality Disorder Criteria With Suicide Attempts	38
Pragmatic Precision Psychiatry—A New Direction for Optimizing Treatment Selection	38
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	38
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status	37
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US	37
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia	37
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months	37
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	37
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	36
Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia	35
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry	35
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	35
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	35
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	35
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care	34
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	33
Prevalence, Comorbidity, and Sociodemographic Correlates of Psychiatric Diagnoses Reported in the All of Us Research Program	33
Structural Magnetic Resonance Imaging All Over Again	33
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection	33
Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems	32
Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data	32
Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis	32
Association of Early-Life Mental Health With Biomarkers in Midlife and Premature Mortality	31
Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic	31
Association Between Brain Structure and Alcohol Use Behaviors in Adults	31
Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence	30
Individual Differences in Response to Antidepressants	30
Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder	30
Tapering Antipsychotic Treatment	30
Prolonged Grief Disorder Diagnostic Criteria—Helping Those With Maladaptive Grief Responses	29
Association of Heavy Drinking With Deviant Fiber Tract Development in Frontal Brain Systems in Adolescents	29
Sex Differences in Mental Health Problems and Psychiatric Hospitalization in Autistic Young Adults	29
Comparing Copy Number Variations in a Danish Case Cohort of Individuals With Psychiatric Disorders	29
Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression	29
Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China	29
The Rise of Venture Capital Investing in Mental Health	28
Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder	28
Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders	28
Association of Childhood Adversities With Suicide Ideation and Attempts in Puerto Rican Young Adults	28
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	28
Association of Everyday Discrimination With Depressive Symptoms and Suicidal Ideation During the COVID-19 Pandemic in the All of Us Research Program	28
Effect of Matching Therapists to Patients vs Assignment as Usual on Adult Psychotherapy Outcomes	28
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	28
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	28
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	28
Association of Mitochondrial Biogenesis With Variable Penetrance of Schizophrenia	28
Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizoph	28
Association of Insulin Resistance With Depression Severity and Remission Status	28
Multivariate, Transgenerational Associations of the COVID-19 Pandemic Across Minoritized and Marginalized Communities	27
Association of Toxoplasma gondii Seropositivity With Cognitive Function in Healthy People	27
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	27
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases	26
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease	26
Attenuated Psychosis Syndrome or Pharmacologically Attenuated First-Episode Psychosis?	26
Clinical Characterization of Copy Number Variants Associated With Neurodevelopmental Disorders in a Large-scale Multiancestry Biobank	26
Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression	26
Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression	26
Association of Task-Shared Psychological Interventions With Depression Outcomes in Low- and Middle-Income Countries	26
The Development of Kraepelin’s Concept of Dementia Praecox	25
Maternal Mental Health and Infant Development During the COVID-19 Pandemic	25
Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder	25
Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder	25
Effect of 3 Forms of Early Intervention for Young People With Borderline Personality Disorder	25
Association of Parent-Reported Sleep Problems in Early Childhood With Psychotic and Borderline Personality Disorder Symptoms in Adolescence	25
Development and Validation of a Model to Predict Posttraumatic Stress Disorder and Major Depression After a Motor Vehicle Collision	25
Transforming Mental Health Care Delivery Through Implementation Science and Behavioral Economics	25
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	25
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	25
Association Between Depression and Physical Conditions Requiring Hospitalization	25
Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia	25
Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents	24
Trends in Acute Care Use for Mental Health Conditions Among Youth During the COVID-19 Pandemic	23
The Subjective Experience of Childhood Maltreatment in Psychopathology	23
Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder	23
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness	23
Heritability of Psychotic Experiences in Adolescents and Interaction With Environmental Risk	23
Global Mental Health Services and the Impact of Artificial Intelligence–Powered Large Language Models	22
The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic	22
Ketamine vs Electroconvulsive Therapy for Major Depressive Episode	22
Emerging Challenges for Psychedelic Therapy	22
Applying Anti-racism to Clinical Care and Research	21
Effect of Incentives for Alcohol Abstinence in Partnership With 3 American Indian and Alaska Native Communities	21
The Heterogeneity of Posttraumatic Stress Disorder in DSM-5	21